Timely Testing For GDM
There are select groups of women including African American, American Indian or Alaska Native, Asian American, Hispanic or Latino, and Native Hawaiian or Pacific Islanders that are at greater risk for being diagnosed with GDM. Early identification can greatly improve the birth outcomes for these women. Additionally, consumers that meet the below criteria should also receive their OGTT early in pregnancy:
- Diagnosed with GDM during a prior pregnancy
- Known impaired glucose metabolism
- Gave birth to a baby weighing more than 9 lbs
- Obesity with BMI greater than 30
- Polycycstic ovarian syndrome
Patients who don't meet one or more of these defined criteria should receive their OGTT test between 24 and 28 6/7 weeks gestation.
Postpartum Testing for T2DM
ACOG currently recommends providing an OGTT test between 4-12 weeks postpartum to identify patients' risk for Type 2 Diabetes. Scheduling the test either prior to delivery or while the consumer is in the hospital immediately following, may increase the likelihood of receipt of the test. If the consumer tests negative for T2DM, she should follow up subsequently every three years to test her risk for it in the future. If upon receipt of the test she is identified as being pre-diabetic that test should occur annually. However, if she tests positive for T2DM, she should establish regular appointments with a Primary Care Provider (PCP) and participate in self-management education and connect with a Dietician and/or Diabetes Educator to establish a care plan moving forward. Coordinating care among OBGYNs, PCPs, and Diabetes professionals is essential to ensure all future pregnancies are healthy and your consumer's condition is properly monitored.